Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors.

Eur J Pediatr

Service de Pédiatrie II, Hôpital de Hautepierre, Strasbourg, France.

Published: January 1989

AI Article Synopsis

  • Three premature babies exposed in utero to prostaglandin synthetase inhibitors (PSI) and corticosteroids experienced renal dysfunction at birth.
  • One infant had transient water and sodium retention leading to uraemia, while twins suffered from severe acute renal failure and high potassium levels (hyperkalaemia).
  • The renal issues may stem from disrupted prostaglandin-mediated adaptation to stress due to PSI exposure, and the corticosteroids could have played a role in inhibiting prostaglandin synthesis.

Article Abstract

Three cases of renal dysfunction at birth were observed in premature babies exposed in utero to prostaglandin synthetase inhibitors (PSI) and corticosteroids. Transient water and sodium retention with uraemia occurred in one patient, and severe acute renal failure with marked hyperkalaemia in twins. These findings may be due to impairment of prostaglandin (PG)-mediated renal adaptation to stress conditions after transplacental passage of PSI. Corticosteroids may also have affected PG synthesis inhibition.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00444137DOI Listing

Publication Analysis

Top Keywords

renal dysfunction
8
psi corticosteroids
8
neonatal renal
4
dysfunction intrauterine
4
intrauterine exposure
4
exposure prostaglandin
4
prostaglandin synthesis
4
synthesis inhibitors
4
inhibitors three
4
three cases
4

Similar Publications

Background: Postoperative acute kidney injury (AKI) and chronic kidney disease (CKD) following pediatric liver transplantation (PLT) have not been comprehensively studied. This study aimed to evaluate the correlation between AKI and both 1-year CKD and mortality.

Methods: This retrospective study included 132 children aged between 3 months and 12 years who underwent PLT between 2017 and 2021.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a common clinical condition with significant health risks for patients and is widely recognised as a major public health concern. Laboratory medicine plays a crucial role in both diagnosing and managing CKD, as diagnosis and staging rely on estimated glomerular filtration rate (GFR) and evaluating albuminuria (or proteinuria). It was evident that the laboratory assessment of CKD in Malaysia is not standardised.

View Article and Find Full Text PDF

Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population.

Lipids Health Dis

December 2024

Department of Nephrology, The Fourth Affiliated Hospital, Guangxi Medical University, Liuzhou, Guangxi, 545005, People's Republic of China.

Background: Lipid metabolism is influenced by mutations in the EH domain binding protein 1 gene (EHBP1). This study investigated the link between the EHBP1 single-nucleotide polymorphisms (SNPs) and dyslipidemia risks in maintenance dialysis patients with end-stage renal disease in Chinese Han population.

Methods: A total of 539 patients were divided into dyslipidemia (379) and control (160) groups.

View Article and Find Full Text PDF

Patients with chronic kidney disease have a high incidence of cardiovascular diseases, and autonomic dysfunction has a determinant role in the relevant declines. Physical exercise influences heart rate variability and cardiac autonomic modulation. Thus, our objective was to systematically review, with a meta-analysis, the correlation between physical exercise interventions and alterations in cardiac autonomic modulation in hemodialysis patients.

View Article and Find Full Text PDF

Disruptions in cognitive function have been reported in individuals undergoing haemodialysis and those with chronic kidney disease. This pilot study protocol primarily assesses the feasibility and acceptability of using mobile cognitive gaming apps for patient-led cognitive training during haemodialysis sessions. The protocol consists of three phases: (1) reviewing and evaluating available cognitive gaming apps, (2) conducting focus groups/interviews with people with kidney disease to determine app preferences, and (3) undertaking a quasi-experimental randomised controlled trial to compare cognitive outcomes between a patient-led app intervention group and a standard care control group over four months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!